|
Task Force on Environmental Health Risks and Safety Risks to Children: Coordinated Federal Action Plan to Reduce Racial and Ethnic Asthma Disparities
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG
|
NHLBI, NCMHD, NIAID, NICHD, NIEHS, NINR
|
The Action Plan to Reduce Asthma Disparities promotes collaboration and coordination among Federal agencies to leverage existing resources to address the multi-leveled causes of asthma disparities. The Action Plan outlines four key strategies to improve the quality of care for children who have asthma and promote community programs and resources to support clinicians, children, and their families in following best practices for asthma management.
|
|
TB Diagnostics Research Forum
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NIAID
|
The purpose of the forum is to communicate, coordinate, and collaborate to address issues of tuberculosis (TB) diagnostics, especially drug susceptibility testing (DST) for new drugs and regimens. The initial focus was to bring together researchers, clinicians, clinical trial groups, government, and non‐government organizations with both the drug and diagnostic industry to advance the field of pyrazinamide DST to meet the needs of clinical trials. In addition, the Forum will expand to other drugs including new anti-tuberculosis drugs in the pipeline.
|
|
TB Therapeutics Research Coordination Forum
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NIAID
|
The purpose of the TB (Tuberculosis) Therapeutics Research Coordination Forum (“the Forum”) is to support and sustain discussion, information sharing, and decision making to coordinate clinical trials of new TB drug combinations. The overall goal is to advance new therapies rapidly and cost-effectively while maintaining the highest standards of scientific rigor. The Forum will work to coordinate planning among the major non-commercial sponsors and their research groups to ensure rapid and efficient Phase II evaluations of drug combinations.
|
|
Technical and Clinical Consultation to Indian Health Service in Kidney Disease
|
Public Education Campaign
|
IHS
|
NIDDK
|
A National Institute of Diabetes and Digestive and Kidney Diseases senior staff member serves as Chief Clinical Consultant for Nephrology for the Indian Health Service.
|
|
Technical Consultation on HCV Infection in Young IDUs
|
Meeting/ Workshop
|
CDC, OS, SAMHSA
|
NIDA, NIAID, NIDDK
|
Bring Federal and non-Federal clinician/researchers from academia, state public health departments and community to present and discuss current research and other information on an emerging epidemic of viral hepatitis (HCV) infection in the 15-30 year group.
|
|
Text 4 Baby Program Evaluation Technical Advisory Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, HRSA, OS, SAMHSA
|
NICHD
|
Formal program evaluation of the Text 4 Baby initiative, which provides health info to pregnant women and young mothers via text message.
|
|
Text4baby
|
Public Education Campaign
|
ACF, AHRQ, CDC, CMS, HRSA, IHS, SAMHSA
|
NIDCR, NICHD, NIDA, NIDDK
|
Free health text messaging service for pregnant women and new mothers. Those who text "BABY" (or “BEBE” for Spanish) to 511411 receive weekly text messages, timed to their due date or their baby''s birth date through the baby’s first year. Messages, which have been vetted by both government and non-profit health experts, deal with topics such as nutrition, immunization, birth defect prevention, and oral health.
|
|
The CDC Dental, Oral, and Craniofacial Data Resource Center (DRC)
|
Resource Development
|
CDC
|
NIDCR
|
Publicly accessible database, query system, and survey catalog for population-based oral health surveys
|
|
The Environmental Determinants of Diabetes in the Young (TEDDY)
|
Research Initiative
|
CDC
|
NIDDK, NIAID, NICHD, NIEHS
|
This consortium is organizing international efforts to identify infectious agents, dietary factors, or other environmental factors that trigger type 1 diabetes in genetically susceptible people. The study enrolled over 8,000 newborns and is following them for 15 years to identify environmental triggers of type 1 diabetes.
|
|
The Epidemiology of Burkitt Lymphoma in East-African Children and Minors (EMBLEM)
|
Research Initiative
|
CDC
|
NCI
|
EMBLEM provides a unique infrastructure to obtain valuable data and samples to study Burkitt’s lymphoma (BL) epidemiology. Study data will help characterize or investigate: 1. The association of malaria-resistance genes with endemic BL. 2. Host genetic polymorphisms associated with BL using genome-wide association methods. 3. The role of the Epstein-Barr virus (EBV) genetic variants in endemic BL. 4. The role of malaria immunology and phenotype of inflammation in BL. 5. The complexity of coinfection with different P. falciparum malaria genotypes in BL. 6. The interaction between helminthic parasites, HIV, malaria, and EBV in BL. 7. The immunohistochemistry and molecular pathology of BL. 8. The impact of malaria, helminthic parasites, and HIV on childhood BL.
|